Anne John

A molecular classification of human mesenchymal stromal cells

Extracellular Matrix Reorganization During Wound Healing and Its Impact on Abnormal Scarring

Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

Flavonoids as natural phenolic compounds and their role in therapeutics: an overview

The renin–angiotensin system and cancer: old dog, new tricks

Influence of Metabolism on Epigenetics and Disease

mixOmics: An R package for ‘omics feature selection and multiple data integration

Transcriptomic Analyses of Myeloid-Derived Suppressor Cell Subsets in the Circulation of Colorectal Cancer Patients

Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity

Molecular targets of luteolin in cancer

Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

Discoidin domain receptor tyrosine kinases: new players in cancer progression

Ubiquitin-dependent regulation of COPII coat size and function

Extracellular matrix structure

Natural product-based nanoformulations for cancer therapy: Opportunities and challenges

Remodelling the extracellular matrix in development and disease

Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels

Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities

Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy

Discoipyrroles A–D: Isolation, Structure Determination, and Synthesis of Potent Migration Inhibitors from Bacillus hunanensis

Luteolin Sensitizes Two Oxaliplatin-Resistant Colorectal Cancer Cell Lines to Chemotherapeutic Drugs Via Inhibition of the Nrf2 Pathway

Cisplatin in cancer therapy: Molecular mechanisms of action

Cytotoxicity of dietary flavonoids on different human cancer types

Luteolin induces apoptotic cell death via antioxidant activity in human colon cancer cells

Epigenetic mechanisms in anti‐cancer actions of bioactive food components – the implications in cancer prevention

Tannic Acid with Antiviral and Antibacterial Activity as A Promising Component of Biomaterials—A Minireview

Delineation of the Clinical, Molecular and Cellular Aspects of Novel JAM 3 Mutations Underlying the Autosomal Recessive Hemorrhagic Destruction of the Brain, Subependymal Calcification, and Congenital Cataracts

Natural Polyphenols for Prevention and Treatment of Cancer

Marine natural products

Transmembrane Collagen Receptors

Flavonoids in Cancer and Apoptosis

Kaempferol: A Key Emphasis to Its Anticancer Potential

Luteolin Nanoparticle in Chemoprevention: In Vitro and In Vivo Anticancer Activity

Remodeling of tannic acid crosslinked collagen type I induces apoptosis in ER+ breast cancer cells.

Inhibition of hypoxia-induced epithelial mesenchymal transition by luteolin in non-small cell lung cancer cells

DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer

Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells

Captopril as a Potential Inhibitor of Lung Tumor Growth and Metastasis

Trafficking defects and loss of ligand binding are the underlying causes of all reported DDR2 missense mutations found in SMED-SL patients

Endoplasmic Reticulum Quality Control Is Involved in the Mechanism of Endoglin-Mediated Hereditary Haemorrhagic Telangiectasia